Abstract
OBJECTIVE: C-reactive protein (CRP), a nonspecific inflammatory marker, may be associated with the development of cardiovascular disease (CVD) among adults. The purpose of this study is to evaluate the relation between plasma CRP levels and 5-y body weight and body mass index (BMI) change among school children in Taiwan.
METHOD: In 1995, we conducted an epidemiological survey to evaluate the anthropometric characteristics and CVD risk factors among 1500, aged 12–15 y, school children in Taipei. We measured plasma high sensitivity CRP levels using nephelometric method. In 2000, we followed these children to evaluate their changes in body height, weight and BMI during 5 y.
RESULTS: In general, boys were taller, heavier and had higher BMI than girls at the baseline (1995) and at the 5-y follow-up (2000). Baseline plasma CRP levels were positively correlated with body weight and BMI in both 1995 and 2000. However, plasma CRP levels were negatively correlated with 5-y BMI change in both genders. We further divided the children into three subgroups based on their baseline CRP levels (nondetected, 0.188–1.00 and >1.0 mg/dl). Children in the higher plasma CRP levels (>1.0 mg/dl) were heavier and had higher BMI (both in 1995 and 2000) than those children with nondetected CRP levels. However, children with higher CRP subgroup had a lower 5-y increasing of BMI and there was even a decrease of BMI levels among the higher CRP girls.
CONCLUSION: From this prospective study, we found that baseline plasma CRP levels were positively correlated with the baseline and the 5-y follow-up body weight and BMI in both genders. However, plasma CRP levels may not be a good predictor of 5-y body weight and BMI changes among children in Taiwan.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Garrow JS . Health implications of obesity. Obesity and related diseases. London: Churchill Livingstone; 1988. pp 1–16.
Gidding SS . A perspective on obesity. Am J Med Sci 1995; 310 (Suppl 1): S68–S71.
Bray GA . Health hazards of obesity. Endocrinol Metab Clin North Am 1996; 25: 907–919.
Dietz WHJ . Obesity in infants, children, and adolescents in the United States. I. Identification, natural history, and aftereffects. Nutr Res 1981; 1: 117–137.
Aristimuno GG, Foster TA, Voors AW, Srinivasan SR, Berenson GS . Influence of persistent obesity in children on cardiovascular risk factors: the Bogalusa Heart Study. Circulation 1984; 69: 895–904.
Smoak CG, Burke GL, Webber LS, Harsha DW, Srinivasan SR, Berenson GS . Relation of obesity to clustering of cardiovascular disease risk factors in children and young adults. The Bogalusa Heart Study. Am J Epidemiol 1987; 125: 364–372.
Guillaume M, Lapidus L, Bjorntorp P, Lambert A . Physical activity, obesity, and cardiovascular risk factors in children. The Belgian Luxembourg Child Study II. Obes Res 1997; 5: 549–556.
Lauer RM, Clarke WR . Childhood risk factors for high adult blood pressure: the Muscatine Study. Pediatrics 1989; 84: 633–641.
Gidding SS, Bao W, Srinivasan SR, Berenson GS . Effects of secular trends in obesity on coronary risk factors in children: the Bogalusa Heart Study. J Pediatr 1995; 127: 868–874.
Gidding SS, Leibel RL, Daniel S, Rosenbaum M, van Horn L, Marx GR . Understanding obesity in youth. Circulation 1996; 94: 3383–3387.
Dietz WH . Childhood weight affects adult morbidity and mortality. J Nutr 1998; 128 (Suppl 2): 411S–414S.
Braddon F, Rodgers B, Wadsworth M, Davies J . Onset of obesity in a 36 year birth cohort study. BMJ 1986; 293: 299–303.
Serdula MK, Ivery D, Coates RJ, Freedman DS, Williamson DF, Byers T . Do obese children become obese adults? A review of the literature. Pre Med 1993; 22: 167–177.
Clarke WR, Lauer RM . Does childhood obesity track into adulthood? Crit Rev Food Sci Nutr 1993; 33: 423–430.
Guo SS, Roche AF, Chumlea WC, Gardner JC, Siervogel RM . The predictive value of childhood body mass index values for overweight at age 35. Am J Clin Nutr 1994; 59: 810–819.
Must A, Jacques PF, Dallal GE, Bajema CJ, Dietz WH . Long-term morbidity and mortality of overweight adolescents. A follow-up of the Harvard Growth Study of 1922 to 1935. N Engl J Med 1992; 327: 1350–1355.
Steel DM, Whitehead AS . The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today 1994; 15: 81–88.
Danesh J, Collins R, Appleby P, Peto R . Fibrinogen, C-reactive protein, albumin or white cell count: meta-analyses of prospective studies of coronary heart disease. JAMA 1998; 79: 1477–1482.
Ridker PM, Rifai N, Pfeffer MA, Sacks FM, Braunwald E . Long-term effects of pravastatin on plasma concentration of C-reactive protein. Circulation 1999; 100: 230–235.
Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC . C Reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ 1996; 312: 1061–1065.
Rohde LEP, Hennekens CH, Ridker PM . Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men. Am J Cardiol 1999; 84: 1018–1022.
Tracy RP, Lemaitre RN, Pasty BM, Ives DG, Evans RW, Cushman M, Meilahn EN, Kuller LH . Relationship of C-reactive protein to risk of cardiovascular disease in the elderly: results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol 1997; 17: 1121–1127.
Palosuo T, Husman T, Koistinen J, Aho K . C-reactive protein in population samples. Acta Med Scand 1986; 220: 175–179.
Alvarez C, Ramos A . Lipids, lipoproteins, and apoproteins in serum during infection. Clin Chem 1986; 32: 142–145.
Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB . Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999; 282: 2131–2135.
Ford ES . Body mass index, diabetes, and C-reactive protein among U.S. adults. Diabetes Care 1999; 22: 1971–1977.
Haverkate F, Thompson SG, Pyke SD, Gallimore JR, Pepys MB . Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disability Angina Pectoris Study Group. Lancet 1997; 349: 462–466.
Ridker PM, Glynn RJ, Hennekens CH . C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation 1998; 97: 2007–2011.
Cook DG, Mendall MA, Whincup PH, Carey IM, Ballam L, Morris JE, Miller GJ, Strachan DP . C-reactive protein concentration in children: relationship to adiposity and other cardiovascular risk factors. Atherosclerosis 2000; 149: 139–150.
Lagrand WK, Visser CA, Hermens WT, Niessen HWM, Verheugt Freek WA, Wolbink GJ, Hack CE . C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon? Circulation 1999; 100: 96–102.
Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB . Low-grade systemic inflammation in overweight children. Pediatrics 2001; 107: E13.
Cook DG, Mendall MA, Whincup PH, Carey IM, Ballam L, Morris JE, Miller GJ, Strachan DP . C-reactive protein concentration in children: relationship to adiposity and other cardiovascular risk factors. Atherosclerosis 2000; 149: 139–150.
Chu NF, Rimm EB, Wang DJ, Liou HS, Shieh SM . Clustering of cardiovascular disease risk factors among obese schoolchildren: the Taipei Children Heart Study. Am J Clin Nutr 1998; 67: 1141–1146.
Chu NF, Rimm EB, Wang DJ, Liou HS, Shieh SM . Relationship between anthropometric variables and lipid levels among school children: the Taipei Children Heart Study. Int J Obes Relat Metab Disord 1998; 22: 66–72.
Robert WL, Sedrick R, Moulton L, Spencer A, Firai N . Evaluation of four automated high sensitivity C-reactive protein method: implications for clinical and epidemiological applications. Clin Chem 2000; 46: 461–468.
Agrawal A, Kilpatrick JM, Volanakis JE . Structure and function of human C-reactive protein. In: Mackiewicz A, Kushner I, Baumann H (eds). Acute phase proteins. molecular biology, biochemistry, and clinical applications. CRC Press Inc: Boca Raton, FL; 1993: pp 79–92.
Festa A, D'Agostino Jr R, Williams K, Karter AJ, Mayer-Davis EJ, Tracy RP, Haffner SM . The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord 2001; 25: 1407–1415.
Lemieux I, Pascot A, Prud'homme D, Almeras N, Bogaty P, Nadeau A, Bergeron J, Despres JP . Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity. Arterioscler Thromb Vascu Biol 2001; 21: 961–967.
Hak AE, Stehouwer CD, Bots ML, Polderman KH, Schalkwijk CG, Westendorp IC, Hofman A, Witteman JC . Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women. Arterioscler Thromb Vasc Biol 1999; 19: 1986–1991.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chu, NF., Chang, JB. & Shieh, SM. Plasma C-reactive protein concentrations in relation to 5-year body weight change among children: the Taipei Children Heart Study. Int J Obes 27, 735–739 (2003). https://doi.org/10.1038/sj.ijo.0802274
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijo.0802274
Keywords
This article is cited by
-
Inflammation Markers Predict Increased Weight Gain in Smoking Quitters
Obesity Research (2003)